EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time we Bring Trials to People”

Dawn P Richards iD, John Queenan, Linnea Aasen-Johnston, Heather Douglas, Terry Hawrysh, Michael Lapenna, Donna Lillie, Emily I McIntosh, Jenna Shea, Maureen Smith, Susan Marlin

Therapeutic Innovation & Regulatory Science · 2024

DOI: 10.1007/s43441-024-00665-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Dawn P Richards und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trials Ontario, MaRS Centre, West Tower, 661 University Avenue, Suite 460, M5G 1M1, Toronto, ON, Canada. dawn.richards@ctontario.ca. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Public Opinion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Trials Ontario.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little is known about patient and the public perspectives on decentralized and hybrid clinical trials in Canada.

Methods

We conducted an online survey (English and French) promoted on social media to understand perspectives of people in Canada about decentralized and hybrid clinical trials. The survey had two sections. We co-produced this project entirely with patient, caregiver, and family partners.

Results

The survey had 284 (14 French) individuals who started or completed Section 1, and 180 (16 French) individuals who started or completed Section 2. People prefer to have options to participate in clinical trials where aspects are decentralized or hybridized. 79% of respondents preferred to have options related to study visits. There were concerns about handling adverse events or potential complications in decentralized trials, however, communication options such as a dedicated contact person for participants was deemed helpful. Most respondents were amenable to informed consent being done at a satellite site closer to home or via technology and were split on privacy concerns about this. Most preferred travel to a site within an hour, depending on what the trial was for or its impact on quality of life. Due to the response rate, we were unable to explore associations with gender, age, health status, geography, ethnicity, and prior clinical trial participation.

Conclusion

Our findings indicate an openness in Canada to participating in trials that decentralize or hybridize some aspects. These trials are perceived to provide benefits to participants and ways to increase equity and accessibility for participants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicPublic OpinionHumansCanadaMaleAdultMiddle AgedFemaleAgedSurveys and QuestionnairesYoung AdultInformed ConsentSocial MediaAdolescent

Stichwörter der Autor:innen

Decentralized clinical trialsHybrid clinical trialsPatient PerceptionsPatient PerspectivesPublic perceptionsPublic perspectivesSurvey

Autor:innen und Institutionen

  • Clinical Trials Ontario, MaRS Centre, West Tower, 661 University Avenue, Suite 460, M5G 1M1, Toronto, ON, Canada. dawn.richards@ctontario.ca.
  • Department of Public Health Sciences, Queen's University, K7L 3N6, Kingston, ON, Canada.
  • BESPOKE Business Solutions Inc, 135 Coons Road, L4E 2M9, Richmond Hill, ON, Canada.
  • College of Lived Experience Member, Clinical Trials Ontario, MaRS Centre, West Tower, 661 University Avenue, Suite 460, M5G 1M1, Toronto, ON, Canada.
  • Clinical Trials Ontario, MaRS Centre, West Tower, 661 University Avenue, Suite 460, M5G 1M1, Toronto, ON, Canada.

ORCID-Profile: Dawn P Richards

Förderung

  • Clinical Trials Ontario

Zitieren

APA

Richards, D. P., Queenan, J., Aasen-Johnston, L., Douglas, H., Hawrysh, T., Lapenna, M., Lillie, D., McIntosh, E. I., Shea, J., Smith, M., & Marlin, S. (2024). Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time we Bring Trials to People”. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00665-y

Vancouver

Richards DP, Queenan J, Aasen-Johnston L, Douglas H, Hawrysh T, Lapenna M, et al. Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time we Bring Trials to People”. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00665-y

BibTeX
@article{Richards2024,
  author = {Richards, Dawn P and Queenan, John and Aasen-Johnston, Linnea and Douglas, Heather and Hawrysh, Terry and Lapenna, Michael and Lillie, Donna and McIntosh, Emily I and Shea, Jenna and Smith, Maureen and Marlin, Susan},
  title = {Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time we Bring Trials to People”},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2024},
  doi = {10.1007/s43441-024-00665-y}
}
Kostenlos starten →